• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

伊胡-地中海感染研究是否会影响吉利德科学公司的股价？

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

作者信息

Chabrière E

机构信息

Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

出版信息

New Microbes New Infect. 2021 Jan;39:100711. doi: 10.1016/j.nmni.2020.100711. Epub 2020 Sep 30.

DOI:10.1016/j.nmni.2020.100711
PMID:33014379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7525330/
Abstract

During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.

摘要

在新冠疫情期间，吉利德科学公司的股价大幅上涨且波动剧烈。这些波动初步被认为与有关瑞德西韦或羟氯喹/阿奇霉素治疗的沟通、出版物或泄密事件有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2957/7786120/cc9b28859e42/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2957/7786120/4470ca524535/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2957/7786120/cc9b28859e42/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2957/7786120/4470ca524535/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2957/7786120/cc9b28859e42/gr2.jpg

相似文献

1
Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?伊胡-地中海感染研究是否会影响吉利德科学公司的股价？
New Microbes New Infect. 2021 Jan;39:100711. doi: 10.1016/j.nmni.2020.100711. Epub 2020 Sep 30.
2
Corporate Moral Responsibility, Distributive Justice, the Common Good, and Catholic Social Teaching: The Case of Gilead Sciences and Remdesivir.企业道德责任、分配正义、共同利益与天主教社会教义：吉利德科学公司与瑞德西韦的案例
Linacre Q. 2023 Nov;90(4):437-451. doi: 10.1177/00243639221116216. Epub 2022 Aug 22.
3
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences.利益冲突对新冠疫情时代公众立场的影响：吉利德科学公司案例
New Microbes New Infect. 2020 Jun 6;38:100710. doi: 10.1016/j.nmni.2020.100710. eCollection 2020 Nov.
4
COVID-19 Management at IHU Méditerranée Infection: A One-Year Experience.法国地中海传染病医疗与教学研究所（IHU）对新冠病毒病的管理：一年经验
J Clin Med. 2021 Jun 29;10(13):2881. doi: 10.3390/jcm10132881.
5
'Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences' by Roussel and Raoult (2020).鲁塞尔和拉乌尔（2020年）所著的《新冠疫情时代利益冲突对公共立场的影响：吉利德科学公司案例》
New Microbes New Infect. 2020 Jul 18;37:100730. doi: 10.1016/j.nmni.2020.100730. eCollection 2020 Sep.
6
COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.新型冠状病毒疾病药物氯喹和羟氯喹，但不是阿奇霉素和瑞德西韦，可阻断 hERG 钾通道。
J Pharmacol Exp Ther. 2021 May;377(2):265-272. doi: 10.1124/jpet.120.000484. Epub 2021 Mar 5.
7
Contagion Management at the Méditerranée Infection University Hospital Institute.地中海感染大学医院研究所的传染病管理
J Clin Med. 2021 Jun 15;10(12):2627. doi: 10.3390/jcm10122627.
8
A business model predicting the impact of live-stream marketing on firms' stock price - An event study.一种预测直播营销对公司股价影响的商业模式——一项事件研究。
Heliyon. 2022 Dec 22;8(12):e12522. doi: 10.1016/j.heliyon.2022.e12522. eCollection 2022 Dec.
9
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.羟氯喹、瑞德西韦和地塞米松在美国 COVID-19 住院成人患者中的使用：一项回顾性队列研究。
Ann Intern Med. 2021 Oct;174(10):1395-1403. doi: 10.7326/M21-0857. Epub 2021 Aug 17.
10
How to face COVID-19: proposed treatments based on remdesivir and hydroxychloroquine in the presence of zinc sulfate. Docking/DFT/POM structural analysis.如何应对 COVID-19：硫酸锌存在时基于瑞德西韦和羟氯喹的治疗建议。对接/DFT/POM 结构分析。
J Biomol Struct Dyn. 2022;40(19):9429-9442. doi: 10.1080/07391102.2021.1930161. Epub 2021 May 25.

本文引用的文献

1
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.羟氯喹联合阿奇霉素作为 COVID-19 患者潜在治疗方法：安全性概况、药物相互作用以及毒性管理。
Microb Drug Resist. 2021 Mar;27(3):281-290. doi: 10.1089/mdr.2020.0232.
2
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
3
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
羟氯喹和阿奇霉素联合治疗至少随访 6 天的 80 例 COVID-19 患者的临床和微生物学效果：一项前瞻性观察研究。
Travel Med Infect Dis. 2020 Mar-Apr;34:101663. doi: 10.1016/j.tmaid.2020.101663. Epub 2020 Apr 11.
4
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
5
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
6
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.基于现有证据对 2019 年新型冠状病毒（SARS-CoV-2）的回顾。
Int J Antimicrob Agents. 2020 Jun;55(6):105948. doi: 10.1016/j.ijantimicag.2020.105948. Epub 2020 Mar 19.
7
COVID-19 and Italy: what next?COVID-19 和意大利：下一步如何？
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
8
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）和 2019 年冠状病毒病（COVID-19）：疫情和挑战。
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
9
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
10
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.预防性和治疗性瑞德西韦（GS-5734）治疗中东呼吸综合征冠状病毒感染恒河猴模型。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.